REGN

Regeneron Pharmaceuticals
D

REGN

Arincen73/100B
904.38
USD
1.56
(0.17%)
Post Trading·904.19USD-0.19(-0.02%)
Last updated: · Delayed 15 min
Fair value814.64Plus+11%346Price 904.381,431
Q4 FY2026 · Earnings report
EPS estimate 25.39Revenue estimate 5.85B
OverviewFinancialsForecastEarningsDividendsCompany

Regeneron Pharmaceuticals market cap

Regeneron Pharmaceuticals's market cap is 93.54B USD: 103,430,712 shares outstanding at today's price of 904.38.

Today
93.54B
Average, 5 years
81.11B
Low, 5 years
51.52B
High, 5 years
129.93B

Market cap = price × shares outstanding = 904.38 × 103.43M = 93.54B

Each day's closing price times the shares outstanding in the last 10-Q or 10-K filed by then (the quarter's basic share count, adjusted for splits); from the latest count on, the shares outstanding now.

Market cap by year and by quarter

Fiscal yearPeriod endingMarket cap
Today93.54B
FY202531 Dec 202580.74B
FY202431 Dec 202476.86B
FY202331 Dec 202393.71B
FY202231 Dec 202277.27B
FY202131 Dec 202166.75B
FY202031 Dec 202051.98B
FY201931 Dec 201941.00B
FY201831 Dec 201842.88B
FY201731 Dec 201743.57B
FY201631 Dec 201642.67B
FY201531 Dec 201562.55B
FY201431 Dec 201446.53B
FY201331 Dec 201330.61B
FY201231 Dec 201219.00B
FY201131 Dec 20115.02B
FY201031 Dec 20102.72B
FY200931 Dec 20091.93B
FY200831 Dec 20081.45B
FY200731 Dec 20071.60B
FY200631 Dec 20061.16B
FY200531 Dec 2005889.61M
FY200431 Dec 2004510.41M
FY200331 Dec 2003742.12M
FY200231 Dec 2002813.50M
FY200131 Dec 20011.19B
FY200031 Dec 20001.24B
FY199931 Dec 1999398.01M
FY199831 Dec 1998226.67M
FY199731 Dec 1997248.24M
FY199631 Dec 1996394.60M
FY199531 Dec 1995251.79M
FY199431 Dec 199456.85M
FY199331 Dec 1993256.62M
FY199231 Dec 1992184.84M
FY199131 Dec 1991281.33M
FY199031 Dec 1990324.64M

See also:P/E ratio,P/S ratio,Dividend yield,ROE (return on equity),Debt to equity,Current ratio,All ratios

Common questions about Regeneron Pharmaceuticals's market cap

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.